LXRα is known to exert anti-inflammatory effects in a wide range of pathophysiological processes and considered to be therapeutically attractive in coronary heart disease and Alzheimer’s disease [54, 55]. This evidence concerns the gene NR1H3 and early-onset autosomal dominant Alzheimer disease.